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ABSTRACT
The estrogen receptor-related receptor gamma
(ERRg/ERR3/NR3B3) is a member of the nuclear
receptor superfamily that activates transcription in
the absence ofligand.However,thedetailed mechan-
ism of gene regulation by ERRg is not fully under-
stood. In this study we have found that the orphan
nuclear receptor ERRg activates the DAX-1 promoter,
which, in turn, represses transactivation by ERRg.
Serial deletions of mouse DAX-1 (mDAX-1) gene pro-
moter have revealed that the region responding to
ERRg is located between  129 and  121 bp and
 334 and  326 bp. Gel shift assays and chromatin
immunoprecipitation (ChIP) assays demonstrated
that ERRg binds directly to the mDAX-1 promoter.
Site-directed mutagenesis results demonstrated
that ERRE1 ( 129 to  121 bp) is more important
than ERRE2 ( 334 to  326 bp) which is not
conserved in the human DAX-1 promoter. In addition,
adenovirus-mediated overexpression of ERRg
induced DAX-1 gene expression in MCF-7 breast can-
cer cells that co-expressed ERRg and DAX-1.
Moreover, yeast two-hybrid and glutathione S-trans-
ferase (GST)-pull down assays demonstrated that
DAX-1 physically interacted with ERRg and inhibited
ERRg transactivation, and that this interaction was
dependent on the AF-2 domain of ERRg. In addition,
in vitro competition assays showed that DAX-1 inhib-
ited PGC-1a mediated ERRg transactivation, via
competition between these two factors for the AF-2
binding domain. We thus propose a novel autoregu-
latory loop that controls DAX-1 gene expression
by ERRg.
INTRODUCTION
Nuclear receptors (NRs) are ligand-dependent transcription
factors that bind to speciﬁc DNA target sequences through
their highly conserved DNA-binding domain (DBD) and
activate transcription through interaction with coactivators.
The latter property is dependent on their moderatelyconserved
ligand-binding domain (LBD) and in particular requires the
extreme C-terminal part of it, the so-called AF-2 region (1).
AmongNRs, DAX-1(dosage-sensitivesexreversal,adrenal
hypoplasia critical region, on chromosome X, gene 1)
(NR0B1) is an atypical orphan nuclear receptor, since it
does not contain a DBD (2,3). Instead, the N-terminal half
of DAX-1 contains a unique region mainly composed of three
repeats, each of which is 65–67 amino acids in length. This
region contains LXXLL motif-like sequences (where L and M
are leucine and methionine, respectively, and X can be any
amino acid) that are necessary for interaction with estrogen
receptors (ERs) (4). Since the C-terminal half of DAX-1 con-
taining the putative LBD functions as a repressor domain
through interaction with corepressors (NCoR) (5), two mech-
anisms have been proposed to function cooperatively in the
repression of transcription exerted by DAX-1. According to
the proposition, DAX-1 would both block the binding of
coactivators to NRs and recruit corepressors with its C-
terminal half (4–6). The DAX-1 gene was identiﬁed through
a search for a gene linked to adrenal hypoplasia congenita,
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cortex and which is often associated with hypogonadotropic
hypogonadism (2,3). Mouse and human DAX-1 promoters
have been cloned and characterized. For example, orphan
nuclear receptor steroidogenic factor-1 (SF-1) regulates
DAX-1 promoter, and the SF-1 response element is located
between  129 and  121 bp on the mouse promoter and
between  135 and  143 bp on the human promoter (7,8).
Estrogen-related receptors (ERRs-alpha, -beta and
-gamma), are orphan NRs closely related to ERs, with
which they share identical target response elements and core-
gulatory proteins (9,10). However, ERRs do not respond to the
classical ER ligand. Previous studies have demonstrated that
MCAD, pS2 and cyp19 are targets of ERRa (11–13). Among
the ERR family, ERRg, the newest member of the subfamily,
is a constitutively active nuclear receptor, and little is known
about its in vivo functions (9,10). Previous studies have
demonstrated that 4-hydroxytamoxifen (4-OHT) directly
binds to and deactivates ERRg, suggesting that 4-OHT is
an inverse agonist of ERRg (14,15). However, the deactivation
mechanism of ERRg by 4-OHT requires further elucidation. It
has been reported that coactivators such as GRIP1 or PGC-1a,
interact directly with ERRg and activate its transcriptional
activity (16,17). ERRg acts as a monomer and activates tran-
scription constitutively. It has also been suggested in recent
reports, that ERRg forms dimers through its LBD. In contrast
to this, the related receptor, ERRa, inhibits the activities of
both ERRa and ERRg through heterodimerization (18). ERRg
exhibits signiﬁcant afﬁnities for binding to a wide spectrum of
sequences, including inverted and direct repeat sequences
composed of AGGTCA half-sites with differing spacings,
as well as a monovalent motif of the same sequence carrying
an extra T(C/G)A trinucleotide on the 50 side (19). It has been
reported that ERRg binds to and transactivates both estrogen
response elements and SF-1 response elements (SF-1RE). Pre-
vious reports have suggested that several monomeric binding
partners, such as SF-1, liver receptor homolog-1 (LRH-1) and
ERRg, can activate and bind directly to the small heterodimer
partner (SHP) promoter through SF-1RE (16,20).
DAX-1 is closely related to SHP, which neither contains a
DNA-binding domain nor functions as a corepressor (2,3). In
addition, both the DAX-1 and SHP promoters are regulated by
the monomer binding partner SF-1. Thus, since the DAX-1
promoter contains several SF-1RE, we predicted that ERRg
couldalso activate the DAX-1 promoter. Transient transfection
studies demonstrated that ERRg had a preferential effect on
the DAX-1 promoter. The results of deletion and site-directed
mutagenesis have revealed that two ERR regulatory elements
(ERREs) are responsible for the ERRg-mediated activation of
the DAX-1 promoter. The results of electrophoretic mobility
shift assay (EMSA) and chromatin immunoprecipitation
(ChIP) assays strongly suggest that ERRg binds directly to
the DAX-1 promoter. In addition, the results of overexpression
and ERRg knock-down experiments demonstrated that ERRg
regulates DAX-1 gene expression in MCF-7 breast cancer cells
and that ERRg and DAX-1 are co-expressed in breast cancer
tissue. The expression of DAX-1 inhibits ERRg transactiva-
tion of its own promoter and DAX-1 competes directly with
the coactivator, PGC-1a, for binding to ERRg. Taken
together, these results suggest that ERRg belongs to a new
autoregulatory loop that governs DAX-1 gene expression.
MATERIALS AND METHODS
Plasmids and DNA construction
pcDNA3/HA-ERRa, b, and g (DAF-2), pcDNA3/HA SF-1,
pcDNA3/HA DAX-1, pcDNA3/HA PGC-1a, pGEX4T-1
DAX-1, B42 ERRg, B42 DAF-2 ERRg, Lex A DAX-1, and
pcDNA3 PGC-1a were described previously (21–23). To gen-
erate the  467 bp DAX-1 promoter region, genomic DNA was
isolated from amouse testicularLeydigcell line,K28and used
as template for PCR. The PCR product was cloned into the
pGL3-basic plasmid (Promega) between the MluI and XhoI
sites. mDAX-1/Luc ( 325 and  121 bp) were made by PCR
using the primer and cloned into pGL3 at MluI and XhoI.
Mutant reporters, mtERRE1/Luc, mtERRE2/Luc and
mtERRE1&2/Luc, were constructed by site-directed mutagen-
esis of the mDAX-1 promoter  467 bp/Luc using the primer.
The mutated sequences are shown in Figure 4A. All clones
were veriﬁed by sequencing analysis.
Cell culture and transient transfection assay
Human embryonic kidney (293T), mouse ﬁbriblast (NIH3T3)
and human breast cancer (MCF-7) cells were maintained with
DMEM in the presence of 10% fetal bovine serum and anti-
biotics (Gibco) in humidiﬁed air containing 5% CO
2 at 37 C.
Cells were transfected, using Superfect and Effectene reagents
(Qiagen Inc., Germany), according to the manufacturer’s
instructions. The total DNA used in each transfection was
adjusted to 1 mg by adding the appropriate amount of
pcDNA3 vector. Approximately 40–48 h post-transfection,
cells were harvested and luciferase activity was measured
and normalized to b-galactosidase activity. Experiments
were performed three times in duplicate.
Glutathione S-transferase (GST)-pull down assay
The indicated GST-fusion proteins or GST protein alone were
expressed in Escherichia coli BL21 (DE3) pLys cultures by
adding 0.2 mM isopropyl-b-D-thiogalactopyranoside (IPTG),
and the cells were extracted. GST-fusion proteins were pre-
bound with a 30 ml aliquot of glutathione-Sepharose beads.
The beads were incubated with transcribed and translated
[
35S]methionine-labeled proteins for 3–4 h at 4 C. The
beads were then washed three times with the washing buffer,
and analyzed by SDS–PAGE and protein bands were visual-
ized by usinga phosphorimaging analyzer. Translated proteins
in vitro (10%) were used as input.
In vitro translation
ERRg and ERRgD AF-2 were transcribed and translated
in vitro using a coupled rabbit reticulocyte system (Promega
Corp., Madison, WI) in the presence of [
35S]methionine
according to the manufacturer’s instructions. The translated
proteins were analyzed by 10% SDS–PAGE and visualized by
autoradiography.
Yeast two-hybrid interaction assay
Yeast two-hybrid interaction assays were performed as
described previously (22). Brieﬂy, LexA only or LexA
fused plasmids, and B42 only or B42 fused plasmids, were
transformed into Saccharomyces cerevisae EGY48, con-
taining the galactosidase reporter plasmid 8H18-34, and
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selection markers. The galactosidase assay on plates was car-
ried out as described previously (22).
Gel mobility shift assays
Double-stranded ERRE oligonucleotides were labeled by
ﬁlling-in with [a-
32P]dCTP, using the Klenow fragment of
DNA polymerase I. The oligonucleotide sequences are depic-
ted in Figure 3A. Bacterially expressed GST only and GST
fused ERRg were puriﬁed using GST-Sepharose beads
(Amersham Bioscience, Inc.). Gel mobility shift assays
(20 ml) contained 10 mM Tris (pH 8.0), 40 mM KCl,
0.05% Nonidet P-40, 6% glycerol, 1 mM DTT, and 1 mgo f
poly (dI-dC). Either 2 mg of GST only, or GST fused ERRg
puriﬁed proteins, were used in each reaction. Competitor oli-
gonucleotides were included at a 50- to 100-fold molar excess
as indicated in the Figure legends. After 15 min incubation on
ice, 10000 c.p.m. of labeled oligonucleotide probe was added
and incubation was continued for another 15 min.
DNA–protein complexes were analyzed by 5% PAGE in
1· TBE. Gels were dried and analyzed by autoradiography.
ChIP assay
The ChIP assay was performed according to the instructions of
the ChIP Assay Kit (Upstate, USA). 293T cells were trans-
fected with 1 mg of pcDNA3 HA-ERRg or pcDNA3 HA and
pGL3  467 bp mDAX-1 using Effectene reagent (Qiagen
Inc., Germany). The cells were ﬁxed with formaldehyde 48
h after transfection and harvested. For immunoprecipitation,
anti-HA antibody (Roche Molecular Biochemicals) was used.
Final DNA extractions were ampliﬁed using pairs of primers
that cover the ERR response region within the mDAX-1 pro-
moter (nt  350 to  100 bp). The primers used for PCR were
as follows: 50-AAAGGAAAT AAGTTAGAGGTCAGAG-30
(Forward) and 50-AGCGCGTCCGCCTCCTCCTCTTGGA-50
(Reverse). MCF-7cells (Figure5C)weretransfectedwith 1mg
of pcDNA3/HA or pcDNA3/HA-ERRg. Soluble chromatin
was immunoprecipitated with anti-HA antibody. Final DNA
extractions were ampliﬁed by 30 cycles of PCR using pairs of
primers that cover the ERR response region within the
hDAX-1 promoter (nt  260 to +6 bp). The primers used
for PCR were as follows: 50-CAG CAT CCA GGC GCT
CGC TCT CC-30 (Forward) and 50-TTC TGC CCA GTG GCT
GCC TCC TGG-50 (Reverse).
Preparation of recombinant adenovirus
The recombinant adenovirus was prepared as described pre-
viously (24). In brief, the cDNA encoding ERRg was cloned
into a pAd-YC2 shuttle vector, which (under the control of the
cytomegalovirus promoter) contains a bovine growth hormone
polyadenylation signal sequence. For homologous recombina-
tion, a pAd-YC2 shuttle vector (5 mg) and a rescue vector,
pJM17 (5 mg), were co-transfected into human embryonic
kidney 293 cells. To purify pure plaques, cell culture super-
natant was serially diluted into serum-free media and incub-
atedwith293cellsat37 Cfor1h.Anequalvolume mixtureof
2· medium and 1% agarose was overlaid on the 293 cells.
After 7 days, plaques that were well isolated were puriﬁed
further and propagated in 293 cells and screened by PCR,
using upstream primers derived from the cytomegalovirus
promoter, and downstream primers from the bovine growth
hormone polyadenylation sequence. Then, the recombinants
were ampliﬁed in 293 cells and were puriﬁed and isolated
using CsCl2 (Sigma). The preparations were collected and
desalted, and titers were determined by counting the number
of plaques.
Immunohistochemistry
Immunohistochemical analysis was performed with nine
human breast cancer tissues. Three sections were cut from
the parafﬁn blocks, deparafﬁnized antigen retrieval by pres-
sure cooker in 10 mM sodium citrate (pH 6.0) at full power for
4 min. The primary antibodies used were rabbit polyclonal
anti-ERRg (Abcam, 1:50) and anti-DAX-1 (Santa Cruz,
1:150). Immunohistochemistry was performed using an EnVi-
sion kit (DAKO, Carpinteria, CA). After preincubation with
blocking serum for 15 min, the primary polyclonal antbody for
ERRg or DAX-1 was added and incubated for 30 min in a
humid chamber followed by a wash with TBS buffer. Slides
were then incubated for 30 min with EnVision peroxidase
reagent (DAKO, Carpinteria, CA).
The slides were then sequentially incubated with DAB (3,3-
diaminobenzidine) chromogen for 5 min, counterstained with
Meyer’s hematoxylin and mounted. Careful rinses with
several changes of TBS were performed between each stage
of the procedure. To assess the speciﬁcity of the immunore-
action, a negative control without the primary antibody or with
pre-immune rabbit serum was performed.
RT–PCR analysis
MCF-7 cells were infected with an adenovirus containing the
ERRg gene (100 pfu/cells). After viral infection for 24 h, cells
were harvested for total RNA isolation using the TRIzol
reagent (Invitrogen Life Technologies) according to the man-
ufacturer’s protocol. The mRNAs of ERRg and DAX-1 were
analyzed by RT–PCR. First-strand cDNA was synthesized
from 1 mg of total RNA utilizing an anchored oligo(dT)
primers and reverse transcriptase. The resulting ﬁrst-strand
cDNA was then ampliﬁed to measure mRNA levels of
ERRg, DAX-1 and b-actin by realizing 28, 28 and 23 cycles
of PCR using speciﬁc primers, respectively. The mRNA levels
of b-actin served as an internal control for the RT–PCR ana-
lysis. The primers used for PCR of ERRg, DAX-1 and b-actin
were as follows: ERRg, forward 50-GACTTGACTCGCCA-
CCTCTC-30 and reverse 50-GTGGTACCCAGAAGCGATG-
T-30; DAX-1, forward 50-CCGCTTGCAGTTCGA GACTGT-
G-30 and reverse 50-CTCATGGTGAACTGCACTACTG-30;
b-actin, forward 50-GTCATCACCATTGGCAATGAG and
reverse 50-CGTCATACTCCTGCTTGCTG-30.
siRNA experiment
The siRNAs for ERRg (si-ERRg/I and /II) were chemically
synthesized (Shamchully Pharm. Co., Ltd), deprotected,
annealed, and transfected according to the manufacturer’s
instructions. MCF-7 cells were transfected with siRNA
using Oligofectamine reagent (Invitrogen Life Technologies).
After transfection for 48 h, total RNA was isolated for RT–
PCR of ERRg (28 cycles), DAX-1 (27 cycles) and b-actin
(20 cycles) as a control. The sequences of siRNA are as
follows: si-ERRg/I, sense 50-UGG CCA UCA GAA CGG
6758 Nucleic Acids Research, 2005, Vol. 33, No. 21ACU UTT-30; si-ERRg/II sense 50-CGA AGA CCA GUC
CAA AUU ATT-30.
RESULTS
Identification of ERRg as a transcriptional
activator of the DAX-1 promoter
SF-1 has been identiﬁed as an activator of the DAX-1 promoter
(7,8). Since SFRE is also a DNA-binding site for ERRg,w e
speculated that an ERR response element (ERRE) exists in the
DAX-1 promoter. As shown in Figure 1A, two ERREs were
located in the mDAX-1 promoter; ERRE1 ( 129 to  121 bp),
which was previously identiﬁed as an SF-1RE, and a new
ERRE2 ( 334 to  326 bp). Interestingly, ERRE1 is con-
served in both mouse and human promoters, whereas
ERRE2 only exists in the mouse promoter (Figure 1B).
In order to determine whether ERRs regulate the
DAX-1 promoter, we performed transient transfection
assays using the luciferase reporter gene driven by a
 467 bp region from mouse DAX-1 promoter. As shown in
Figure 2A and B, there was strong activation by ERRg in
293T cells and NIH3T3 cells, whereas ERRa and ERRb
did not demonstrate any signiﬁcant effect. As expected,
SF-1, the positive control for the transfection assays, activated
the DAX-1 gene promotersigniﬁcantly. These resultsindicated
that the DAX-1 gene is a speciﬁc target of ERRg, but not of
ERRa or ERRb. In order to investigate the sequences that
were required for ERRg mediated activation, a series of
50 deletions of the DAX-1 promoter were constructed, as
shown in Figure 2C. Since the DAX-1 promoter contains
two ERREs, we designed deletion constructs both with and
without an ERRE. Activation by ERRg was decreased when
the DAX-1 promoter was deleted up to  325 bp, as demon-
strated in Figure 2D. Furthermore, the activation of the DAX-1
promoter by ERRg, was almost lost with the  121 bp DAX-1
construct. These results suggest that ERREs are required for
ERRg response.
Figure1. ERREsontheDAX-1promoter.(A)MouseDAX-1promotersequencesfrom 467to+43relativetotheputativetranscriptionstartsite.Theadenineatthe
transcriptionstartsite(arrow)andTATA-box(underline) aredesignated+1andTATA-box.Thetranslationinitiationcodon(ATG)isunderlinedwiththeencoded
aminoacidsshownbelowthecodons.PutativeERREsarelinedabovetherespectivesequences.(B)SequencealignmentofERRE1andERRE2withinthemouseand
human DAX-1 promoters. The numbers indicate the nucleotide positions:  129 to  21 bp and  135 to  127 bp in mouse and human ERRE1, respectively, and
 334 to  326 bp and  347 to  339 bp in mouse and human ERRE2, respectively.
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In order to clarify the speciﬁc binding of ERRg to ERREs, gel
mobility shift assays were performed. As demonstrated in
Figure 3A, we designed both wild-type and mutant probes
that corresponded to ERRE1 and ERRE2. Previously, the
TNAAGGTCA sequence was shown to be a bona ﬁde
ERRE. Within the sequence, the GG dimer is pivotal for
Figure 2. ERRg activatesDAX-1genepromoter.(AandB)TranscriptionalactivationofthemDAX-1-promoterbyERRg,butnotbyERRaandb.293Tcells(A)and
NIH3T3cells(B)cellsweretransientlytransfectedwith200ngofindicatedreportergenetogetherwiththeindicatedconcentrationsofHA-pcDNA3-ERRa,b,g and
SF-1.(C)SchematicdiagramofthemDAX-1promoterdeletionconstructsclonedinthepGL3-basicvector.(D)Mappingthesequencesrequiredforactivationofthe
mDAX-1promoterbyERRg.293Tcellsweretransfectedwith200ngofeachreporterplasmidandERRg expressionplasmidasindicated.Approximately40hafter
transfection, the cells were harvested and luciferase activity wasmeasured and normalizedagainst -galactosidase activity. One representative experiment is shown.
All values represent the mean of duplicate samples, and similar results were obtained in at least three independent experiments. The representative results were
expressed as -fold activation (n-fold) over the value obtained with vector alone with the error bars as indicated.
6760 Nucleic Acids Research, 2005, Vol. 33, No. 21ERRg protein binding. Thus, we substituted GG for the TT
sequence. Figure 3B demonstrates that ERRg formed speciﬁc
complexes with ERRE1 and ERRE2; a 50- or 100-fold molar
excess of unlabeled ERRE1 and ERRE2 competed strongly
with the DNA–protein complex. In order to verify that ERRg
binds to the DAX-1 promoter in vivo, we performed a ChIP
assayusing PCRprimersthatﬂanked bothERRE1 and ERRE2
( 350 to  100 bp). 293T cells were transfected with the
DAX-1 promoter, either with hemagglutinin (HA) only or
with HA-tagged ERRg. As demonstrated in Figure 3C, a
250 bp PCR product ( 350 to  100 bp) was observed in
cells that were transfected with the expression vector for
HA-ERRg but not with the vector expressing only the HA
epitope. This indicated that HA-ERRg formed a speciﬁc
complex with the DAX-1 promoter in vivo. Taken together,
this suggests that ERRg regulates the DAX-1 promoter by
direct binding to ERRE.
ERRE1( 129to 121bp)isessentialfortransactivation
of the DAX-1 promoter by ERRg
In order to verify the functional signiﬁcance of ERRg binding
sites in the DAX-1 promoter, site-directed mutagenesis was
performed on the  467 bp DAX-1 promoter using the primers
as shown in Figure 4A. Wild-type  467 bp/Luc and several
mutant constructs were transiently transfected with ERRg
into 293T cells. The ERRE1 mutation (mtERRE1/Luc) and
double ERRE1 and ERRE2 mutations (mtERRE1&2/Luc)
Figure 3. ERRg bindstoERREintheDAX-1promoter.(A)Thesequencesofwild-type(nt 126to 106and 337to 317)andmutantoligonucleotidesusedfor
the gel retardation assays are depicted. Italic letters indicate the substituted nucleotides in ERRE1 and ERRE2. (B) Gel mobility shift and unlabeled competition
assayswereperformedwiththe
32P-labeledprobes,andrecombinantERRg (2mg)proteinasindicated.Unlabeledoligonucleotideswereaddedascompetitorsat50-
to 100-fold molar excess where indicated. (C) ChIP assay. 293T cells were transfected with expression vectors for HA epitope alone or HA-ERRg with  467 bp
DAX-1-Luc.SolublechromatinfromthesecellswaspreparedandimmunoprecipitatedwithmonoclonalantibodyagainstHA(lanes3and4).The 350  100bp
fragment (250 bp) contains the ERRg binding site and 10% of the soluble chromatin used in the reaction was used as input (lanes 1 and 2). PCR was performed
as described in Figure 3C.
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the DAX-1 promoter whereas the ERRE2 mutation
(mtERRE2/Luc) had a slight effect (Figure 4B). These results
indicated that ERRE1, rather than ERRE2, was essential for
the activation of the DAX-1 promoter by ERRg. Thus, we
conclude that ERRE1 plays a major role in the activation
of the DAX-1 promoter by ERRg.
Induction of DAX-1 gene expression by ERRg in
breast cancer
Previous reports have demonstrated that ERRg is a favorable
biomarker and, possibly, an indicator of hormonal sensitivity
in breast cancer. In addition, DAX-1 has also been detected in
breast cancer tissue (25,26). In order to investigate whether
ERRg can directly regulate DAX-1 gene expression in breast
cancer cells, we introduced ERRg by adenovirus infection
into MCF-7 cells. As demonstrated in Figure 5A, a basal
expression of DAX-1 and ERRg was detected in MCF-7
cells, and DAX-1 mRNA was induced by overexpression of
Ad-ERRg 24 h after infection. Since ERRg is basally
expressed in MCF-7 cells, we further tested whether DAX-1
gene expression is down-regulated by performing knock-
down of endogenous ERRg expression using small interfer-
ing RNA (si-ERRg/I or II) in MCF-7 cells. si-ERRg/I, but not
si-ERRg/II signiﬁcantly reduced endogenous ERRg expres-
sion (Figure 5B). DAX-1 mRNA level was decreased by
knock-down of ERRg by si-ERRg/I, but not by si-ERRg/II,
suggesting that endogenous ERRg can activate DAX-1 expres-
sion. In addition, CHIP assays were performed to conﬁrm the
direct binding of ERRg to the endogenous DAX-1 promoter in
MCF-7 cells. As shown in Figure 5C, ERRg can bind to the
Figure 4. The ERRE1 ( 129 to  121 bp) plays a crucial role in the transactivation of the mDAX-1 promoter by ERRg.( A) Schematic diagrams of wild-type and
mutantmDAX-1promoterconstructsfrom 467to+43bpasindicated.TheputativeERRg bindingsitesareindicatedasERRE1andERRE2.(B)ERRE1isessential
for the activationofthe mDAX-1promoterby ERRg. 293Tcells were co-transfected with 200 ng ofwild-typeor mutantmDAX-1promoterconstructstogether with
200 ng of ERRg expression plasmid. Two days after transfection, cells were harvested for luciferase and -galactosidase assays. The representative results are
expressed as -fold activation (n-fold) over the value obtained with vector alone with the error bars as indicated.
6762 Nucleic Acids Research, 2005, Vol. 33, No. 21DAX-1 promoter in MCF-7 cells (Figure 5C). Next, we ana-
lyzed for co-expression of DAX-1 and ERRg in human breast
cancertissues,usingimmunohistochemistry(Figure5D).Nuc-
lear immunoreactivity of DAX-1 was detected in breast cancer
tissues. The overexpression of ERRg was observed in three out
of nine cases. All of the ERRg-positive cancers co-expressed
the DAX-1 protein(Figure 5D, upper part). Two cancer tissues
that were DAX-1-negative were also negative for ERRg.N o
staining was observed in the negative controls using either
pre-immune rabbit serum or by omitting the primary antibody
(data not shown). These results suggest that ERRg can stimu-
late DAX-1 gene expression in human breast cancer cells.
DAX-1 represses ERRg transactivation of
its own promoter
DAX-1 interacts with several orphan NRs (ER, AR, LRH-1,
SF-1 and Nur77) and represses their transcriptional activity
Figure 5. Co-expression of ERRg and DAX-1 in breast cancer cell. (A) MCF-7 cells were infected with adenoviral vector expressing ERRg (100 pfu/cells). Total
RNA was isolated from cells and analyzed by RT–PCR. (B) The effect of siRNA-ERRg on the mRNA level of DAX-1. Endogenous ERRg gene expression was
inhibitedbytransfectionwitha21ntRNAduplexsiRNA-ERRg/IinMCF-7cells.TheeffectsofsiRNAsonERRg andDAX-1expressionwereassayedbyrealizing
RT–PCR for ERRg, DAX-1, and b-actin as a control. (C) MCF-7 cells were transfected with HA or HA-ERRg. The  260   +6 bp fragment (266 bp) contains the
ERRg bindingsiteand10%ofthesolublechromatinusedinthereactionwasusedasinput(lanes1and2).PCRwasperformedasdescribedinFigure5C.(D)DAX-1
andERRg expressioninhumanbreastcancercells.TheDAX-1-expressingtumorcells(topleft)werealsopositiveforERRg (topright).TheDAX-1-negativecancer
cells were also negative for ERRg (bottom left and right) (original magnification, 200·).
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ERRg mediated transactivation of its own promoter. The res-
ults of transient transfections demonstrated that DAX-1 inhib-
its ERRg activity of the DAX-1 promoter in a dose-dependant
manner (Figure 6A). Since ERRg also activates the SHP pro-
moter, and SHP represses ERRg transactivation of its own
promoter, we examined whether DAX-1 represses the
ERRg-mediated transactivation of the SHP promoter or vice
versa. As demonstrated in Figure 6B and C, DAX-1 and SHP
repressed ERRg transactivation of both the SHP promoter and
the DAX-1 promoter. These results suggest that both DAX-1
and SHP are regulated by ERRg and repress the transcriptional
activity of ERRg through an autoregulatory loop. Since
Figure 6A shows that DAX-1 repressed the transcriptional
activity of ERRg, we examined whether DAX-1 can directly
interact with ERRg, by using a GST-pull down and yeast two-
hybridinteractionassays.AsdemonstratedinFigure7AandB,
DAX-1 interacted with ERRg.Since repression or activation is
dependant on the AF-2 domain, we deleted this domain in
ERRg. As expected, DAX-1 could not interact with ERRg
DAF-2, which demonstrates that the AF-2 domain of ERRg
is crucial for the repressive effect of DAX-1 (Figure 7A). In
the case of DAX-1, an LBD-like region was involved in the
interaction with ERRg (Figure 7B). These results suggest that
DAX-1 interacts directly with the AF-2 surface of ERRg.
Since the AF-2 surface of ERRg is involved in the interac-
tion with DAX-1, we explored the role of coactivator com-
petition in the repression of ERRg activity. As demonstrated in
Figure 8A, PGC-1a, which was described previously as a
coactivator of ERRg, signiﬁcantly increased the activity of
ERRg on the DAX-1 promoter and the co-expression of
DAX-1 with PGC-1a repressed this induction in a dose-
dependant manner. This result suggests that both PGC-1a
and DAX-1 compete for the binding of the AF-2 pocket of
Figure6.DAX-1repressesERRg activity.(A–C)293Tcellswereco-transfectedwith200ngofmDAX-1( 467bp)-Luc,mSHP( 2.2kb)-Luc,300ngofERRg,and
increasing amounts of DAX-1 and SHP as indicated in the figure. The luciferase activities were measured and normalized against b-galactosidase activity. One
representative experiment is shown, and similar results were obtained from at least three independent experiments.
6764 Nucleic Acids Research, 2005, Vol. 33, No. 21Figure 7. ERRg physically interacts with DAX-1. (A) GST only or GST fused to DAX-1 was isolated from bacterial culture and immobilized on glutathione-
Sepharosebeads.Invitrotranscribedandtranslated[
35S]methionine-labeledERRg orERRgD AF-2wasincubatedwithpurifiedGSTfusedreceptorsorGSTaloneas
indicated in the Figure. The complexes were resolved by a 12% denaturing PAGE, and analyzed by autoradiography. (B) A yeast strain EGY48 which contains an
integrated b-galactosidase reporter gene controlled by the LexA-binding site was transformed with the indicated LexA and B42 plasmids. The transformants were
selectedonplatescontainingappropriateselectionmarkers,andassayedforb-galactosidaseactivity.Theresultsshownarethemeanb-galactosidasevaluesfromsix
independent transformant colonies.
Figure8.DAX-1repressesPGC-1a-enhancedtransactivityofERRg byinterferingwithPGC-1abindingtoERRg.(A)293Tcellswereco-transfectedwith200ngof
mDAX-1( 467bp)-Luc,theindicatedconcentrationsofPGC-1aandERRg,andincreasingdosesofDAX-1asindicatedinthefigure.Theluciferaseactivitieswere
measuredandnormalizedagainst-galactosidaseactivity.Onerepresentativeexperiment isshown,andsimilarresultswereobtained fromatleast threeindependent
experiments. (B) GST only or GST fused to ERRg was isolated from bacterial cultures and immobilized on glutathione-Sepharose beads. In vitro transcribed and
translated [
35S]methionine-labeled PGC-1a and unlabeled DAX-1 (3 and 6 ml) were incubated with purified GST fused receptors or GST alone as indicated in the
Figure. The interaction complexes were resolved by 12% denaturing PAGE, and the gels analyzed by autoradiography.
Nucleic Acids Research, 2005, Vol. 33, No. 21 6765ERRg, as demonstrated for other receptors. In order to conﬁrm
the direct competition between DAX-1 and PGC-1a for bind-
ing to ERRg, we performed in vitro competition binding
assays, using PGC-1a and DAX-1 with GST fused ERRg.
The results of this study conﬁrmed the ﬁndings of a previous
report (17). Speciﬁcally,
35S-labeled PGC-1a interacted with
ERRg, and DAX-1 inhibited the interaction between PGC-1a
and ERRg (Figure 8B). In addition, no interaction between
DAX-1 and PGC-1a occurred. Taken together, these obser-
vations suggest that DAX-1 physically inhibits the transcrip-
tional activity of ERRg by competing with PGC-1a for
interaction with ERRg.
DISCUSSION
ERRg is one of the newest members of the orphan nuclear
receptor family. Therefore, the target and molecular mechan-
isms of ERRg have not yet been clearly identiﬁed. In this
study, we demonstrated that ERRg acts as a potential regulator
of DAX-1, which, in turn represses ERRg at a molecular level.
This suggests the existence of an autoregulatory loop.
Although the physiological role of DAX-1 has been clearly
identiﬁed, regulationofthe DAX-1promoterisnotfullyunder-
stood. A previous report demonstrated that SF-1 regulates the
DAX-1 promoter through SFRE (7,8). Even though several
SFREs are located on the DAX-1 promoter, the functional
property of SFRE on the DAX-1 promoter has been charac-
terized only in the region between  129 and  121 bp, which
is conserved in both mouse and human (7). As demonstrated in
Figure 1, ERRE1 is identical to sequences previously identi-
ﬁed as the SFRE. We also characterized a new ERRE2 that
was not previously identiﬁed as an SF-1RE. Although both
ERRE1 and ERRE2 are required for the binding of ERRg, the
data from mutation analysis suggest that ERRE1 is more
responsible for ERRg transactivation than ERRE2 (Figures 3
and 4). In the human DAX-1 promoter, only ERRE1 is present.
However, SF-1 can still activate the DAX-1 promoter. This
demonstrates that ERRE1 is critical for transactivarion (7).
Although all three members (a, b and g) of the ERR family
bound to the same DNA response element (data not shown),
onlyERRg wasabletoactivatetheDAX-1promoter(Figure2).
This suggests that DNA-binding is not completely responsible
for transactivation.
The basal transcriptional activity of ERRa and b is relat-
ively low compared to the high activity of ERRg. This sug-
gests that the basal transcriptional mechanism governing
ERRa and b may be distinct from that of ERRg. A previous
report demonstrated that ERRg is constitutively active,
because ERRg forms a complex with coactivators, such as
SRC-1 (28). It has been suggested that, depending on the
speciﬁc co-regulator recruitment, transcriptional activity can
be very different. Furthermore, since NRs can differentially
modulate target promoters through the recruitment of different
coregulators (29,30), ERRg may regulate target promoters,
such as DAX-1, in a distinctly unique manner, compared to
ERRa and b. Further investigation is necessary to determine
whether ERRg regulation of target promoters differs with
co-regulator recruitment.
Until recently, the ligand for ERRg was unknown, although
4-OHT was reported to be an inverse agonist of ERRg (14,15).
Despite a recent report demonstrating that phenolic acyl
hydrazone is a selective agonist of ERRb and ERRg, further
study will be required to prove that phenolic acyl hydrazone is
a bona ﬁde activator of ERRb and g (31). 4-OHT is widely
used in the treatment of breast cancer and deactivates ERRg
which was proposed as a favorable biomarker in human breast
cancer (25). As demonstrated in Figure 5, both ERRg and
DAX-1 are expressed in breast cancer cells and tissues. Fur-
thermore, ERRg regulated the gene expression of DAX-1 in a
positive manner, demonstrating that the DAX-1 promoter is a
potential target of ERRg in vivo. Although the function of
ERRg and DAX-1 in breast cancer is not completely under-
stood, we speculate that there is both a positive and negative
relationship between DAX-1 and ERRg, since DAX-1 acts as
both a corepressor of ER and ERRg and as a regulator of the
DAX-1 promoter. Recent reports indicated that ERRg regu-
lates the ERRa promoter via a conserved hormone response
element and epidermal growth factor signaling which affects
ERRa transactivation in breast cancer cells (32,33). Since
ERRa, ERRg and PGC-1a are co-expressed in breast cancer,
their physiological function may be signiﬁcantly correlated in
breast cancer tissues.
It has been reported that DAX-1 interacts directly with
various NRs and represses their transcriptional activity (4–6,
21,27). Previous studies have demonstrated that DAX-1 uses
its N-terminal repeating region, deﬁned as the LXXLL-
containing interaction domain, for interaction with NRs
(6). In this study, we demonstrated that the LBD-like region
of DAX-1 interacts with ERRg. We also found that DAX-1
interacts with ERRa and b (data not shown). The AF-2
domain of ERRg was crucial for the interaction with
DAX-1 and acted as a binding surface for competition
with the coactivator PGC-1a (Figure 7). Depending on the
binding region of the nuclear receptor with the corepressor,
the repressive mechanism of the corepressor can be quite
different. When the DBD of the nuclear receptor is involved
in interaction with the corepressor, the DNA-binding of the
nuclear receptor is blocked by the corepressor (34). Inversely,
if the AF-2 domain of the nuclear receptor interacts with the
corepressor, the competition between coactivators and the
corepressor occurs on the AF-2 surface of the nuclear recep-
tor (35). In the case of ERRg, the AF-2 domain interacts with
DAX-1 and acts as a binding surface for interaction with the
coactivator PGC-1a (Figure 8).
Previously, we reported that the SHP promoter is a target of
ERR (16). In the current study, we suggest that DAX-1 is a
target of ERRg. As demonstrated in Figure 6, DAX-1
repressed the transcriptional activity of ERRg on the DAX-1
and SHP promoters. In addition, SHP also inhibited ERRg on
the DAX-1and SHP promoters. Itis very interesting that ERRg
regulates corepressor proteins, such DAX-1 and SHP, which
act as repression modulators. Although both SHP and DAX-1
are involved in the regulation of the corepressor-mediated
transactivation of NRs, their physiological functions are
quite different from each other. While DAX-1 plays a role
in steroidogenic tissues, SHP functions mainly in the liver (1).
We demonstrated that there is a correlation betweenERRg and
DAX-1inbreastcancercells(Figure5).Inthecase ofSHP,we
conﬁrmed using adenovirus that ERRg activated SHP gene
expression in the pancreas, but not in the liver (data not
shown). This demonstrated that tissue-speciﬁc target gene
6766 Nucleic Acids Research, 2005, Vol. 33, No. 21expression is modulated by ERRg. DAX-1 is also differenti-
ally regulated by ERRg, depending on the target tissue. The
modulation of DAX-1 and SHP by ERRg in vivo needs to be
examinedfurther,inordertoidentify the physiological rolesof
ERRg, SHP and DAX-1.
Collectively, as depicted in Figure 9, we hypothesize that
ERRg activates the DAX-1 promoter, which in turn inhibits
ERRg through coactivator competition. In this study, we
demonstrated that DAX-1 is a potential target of ERRg. Our
study provides a new insight into understanding the basic
mechanisms of DAX-1 and ERRg, and is expected to provide
clues for the identiﬁcation of the functions of ERRg.
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